eLaws | eCases | United States Code | Federal Courts |
Home » Rulemaking » Roche Genentech - Comment

Roche Genentech - Comment

Document ID: FDA-2013-D-0068-0008
Document Type: Public Submission
Agency: Food And Drug Administration
Received Date: March 21 2013, at 12:00 AM Eastern Daylight Time
Date Posted: May 20 2013, at 12:00 AM Eastern Standard Time
Comment Start Date: February 4 2013, at 12:00 AM Eastern Standard Time
Comment Due Date: March 21 2013, at 11:59 PM Eastern Standard Time
Tracking Number: 1jx-84c2-6dgs
View Document:  View as format xml

View Comment

See attached file(s)

Attachments:

Roche Genentech GNE Comments to FDA Draft Guidance on Photosafety Evaluation of Pharmaceuticals 032113 FINAL

Title:
Roche Genentech GNE Comments to FDA Draft Guidance on Photosafety Evaluation of Pharmaceuticals 032113 FINAL

View Attachment: View as format pdf

Related Comments

   
Total: 5
International Council for Animal Protection in Pharmaceutical Programmes (ICAPPP) - Comment
Public Submission    Posted: 05/20/2013     ID: FDA-2013-D-0068-0007

Mar 21,2013 11:59 PM ET
Merck & Co, Inc. - Comment
Public Submission    Posted: 05/20/2013     ID: FDA-2013-D-0068-0003

Mar 21,2013 11:59 PM ET
Boehringer Ingelheim Pharmaceuticals, Inc - Comment
Public Submission    Posted: 05/20/2013     ID: FDA-2013-D-0068-0004

Mar 21,2013 11:59 PM ET
Sanofi - Comment
Public Submission    Posted: 05/20/2013     ID: FDA-2013-D-0068-0006

Mar 21,2013 11:59 PM ET
Roche Genentech - Comment
Public Submission    Posted: 05/20/2013     ID: FDA-2013-D-0068-0008

Mar 21,2013 11:59 PM ET